跳至主要内容
临床试验/NCT06449131
NCT06449131已完成2 期

Persistent Pleural Effusion Treatment Following Cardiothoracic Surgery by Platelet-Fibrin Glue: A Clinical Trail

Daryoush Hamidi Alamdari, PhD1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2017年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
19
试验地点
1
主要终点
The rate of air leak that is assessed by Cerfolio classification of the air leak by a single observer

研究概览

简要总结

Persistent pleural effusion is a life-threatening complication after cardiac surgery. The traditional treatment is chest tube drainage, which may not respond to treatment. This study introduces a new noninvasive approach for treating persistent pleural effusion using platelet-rich plasma fibrin glue (PRP-FG). This method has been successfully applied for the treatment of postoperative persistent chylothorax and pneumothorax in previous studies, which significantly decreased morbidity, mortality, and hospital stay.

详细描述

This pilot clinical trial recruited 19 patients at Imam Reza Hospital in Mashhad, Iran (2023) who had developed unilateral or bilateral refractory postoperative effusion resistant to conventional thoracostomy treatment. Treatment success was defined as effusion <50 ml/day after 48 hours, along with symptomatic improvement and no adverse events.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of pleural effusion after cardiac surgery in open-heart surgery
  • patients who sign an informed consent form

排除标准

  • Hemodynamically unstable patients
  • Patients who did not sign an informed consent form

研究组 & 干预措施

patients referred to the cardiac surgery clinic

Other

This clinical trial focused on patients referred to the cardiac surgery clinic of Imam Reza Hospital in Mashhad 2023 who were diagnosed with unilateral or bilateral pleural effusion resistant to conservative management.

干预措施: Platelet-Rich Plasma and Fibrin Glue (Drug)

结局指标

主要结局

The rate of air leak that is assessed by Cerfolio classification of the air leak by a single observer

时间窗: within 48 hours after application of platelet-rich plasma

Continuous: Air leak is Present throughout the respiratory cycle Inspiratory: Present during the inspiration phase of the respiratory cycle. Expiratory: Present only during the expiratory phase of the respiratory cycle Forced expiration: Present only when the patient coughs or forces exhalation.

The number of injections until the bubble stops

时间窗: Through study completion, an average of 40 weeks

PRP-FG (5-7 ml/ kg) was injected into the pleural space through the chest tube.

Patient hospitalization time

时间窗: From the time the patient is admitted to the hospital to the time of discharge

Duration of the patient's stay in hospital, assessed up to 40 weeks

Percentage of patients completely recovered

时间窗: Through study completion, an average of 40 weeks

The treatment was successful if the bubbling was stopped and lung expansion was done.

Rate of radiolucency

时间窗: within 48 hours after application of platelet-rich plasma

The percent area on chest x-ray is almost completely transparent to radiation.

Percentage of untreated patients who died

时间窗: Through study completion, an average of 40 weeks

The bubbling was not stopped, lung expansion was not done and the patient was expired

次要结局

未报告次要终点

研究者

发起方
Daryoush Hamidi Alamdari, PhD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Daryoush Hamidi Alamdari, PhD

Associate professor

Mashhad University of Medical Sciences

研究点 (1)

Loading locations...

相似试验